Clinical Supply Agreement Template for Australia

A Clinical Supply Agreement is a specialized legal contract that governs the supply of investigational products, medical devices, or related materials for clinical trials in Australia. This document creates binding obligations between suppliers (such as pharmaceutical companies or contract manufacturers) and trial sponsors or research institutions, ensuring that clinical trial materials are delivered according to strict regulatory and quality standards.

When do you need this document?

You need a Clinical Supply Agreement whenever you're involved in supplying or receiving investigational products for clinical trials in Australia. This includes situations where pharmaceutical companies supply investigational drugs to hospitals, contract manufacturing organizations provide clinical trial materials to biotechnology companies, or medical research institutes receive supplies from international sponsors. The agreement is also essential when multiple parties are involved in the supply chain, such as when a Clinical Research Organization coordinates between sponsors and trial sites. Given Australia's stringent regulatory environment, having a properly structured agreement protects all parties from potential liability and ensures regulatory compliance throughout the trial period.

Key legal considerations

Several critical legal elements must be addressed in your Clinical Supply Agreement. Supply obligations must clearly specify product quantities, delivery schedules, storage requirements, and quality specifications to prevent disputes. Regulatory compliance clauses should address Good Manufacturing Practice requirements, product labeling standards, and adverse event reporting obligations. Risk allocation provisions are crucial, particularly regarding product liability, recall procedures, and indemnification arrangements. Confidentiality and intellectual property protections must cover proprietary formulations, trial data, and manufacturing processes. Additionally, termination clauses should address what happens to unused supplies and ongoing obligations if the trial is stopped early. Payment terms, including costs for storage, handling, and disposal, require careful consideration to avoid unexpected financial burdens.

Legal requirements in Australia

Australian Clinical Supply Agreements must comply with the Therapeutic Goods Act 1989, which governs the regulation of therapeutic goods including their manufacture, supply, and use in clinical trials. The Therapeutic Goods Administration (TGA) Clinical Trial Handbook provides specific guidelines for supply arrangements, including requirements for product accountability, storage conditions, and distribution records. Good Manufacturing Practice guidelines must be incorporated to ensure product quality and safety standards. The Privacy Act 1988 applies when handling participant health information, requiring appropriate data protection clauses. Contract parties must also consider Australian Consumer Law protections, particularly regarding product defects and misleading conduct. The agreement should reference relevant TGA licenses and approvals, including Clinical Trial Notifications or Clinical Trial Exemptions, and ensure compliance with any conditions attached to these approvals.